High-throughput screening (HTS) is an automated drug discovery technique for identification of active compounds against a compound library. Use HTS readers and integrated assay preparation / analysis workstations to screen your compounds. Identify active compounds against various HTS libraries, including membranes, proteins and peptides and HTS cell lines. Find the best high-throughput screening products in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.
Human Nav1.1 sodium ion channel-expressing, stable replicating cell line (CHO-K1). Cat#: CT6178. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: QPatch™ , IonWorks Quattro®
Human P2X2/P2X3 purinergic receptor -expressing, stable replicating cell line (HEK293). Cat#: CT6179. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: PatchXpress® , FLIPR®
Human KCa2.2 potassium ion channel-expressing, stable replicating cell line (CHO-K1). Cat#: CT6181. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: FLIPR®
Human KCa2.3 potassium ion channel-expressing, stable replicating cell line (CHO-K1). Cat#: CT6182. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: FLIPR®
Human Kir6.2/SUR2A potassium ion channel-expressing, stable replicating cell line (HEK293). Cat#: CT6183. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: FLIPR®
Human P2X1 Purinergic Receptor-expressing, stable replicating cell line (HEK293). Cat#: CT6186. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: PatchXpress® , FLIPR®
Human P2X2 Purinergic Receptor-expressing, stable replicating cell line (HEK293). Cat#: CT6187. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: QPatch™ , FLIPR®
Human P2X3 Purinergic Receptor-expressing, stable replicating cell line (HEK293). Cat#: CT6188. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: PatchXpress® , FLIPR®
Human P2X4 Purinergic Receptor-expressing, stable replicating cell line (HEK293). Cat#: CT6189. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: PatchXpress® , FLIPR®
Human P2X7 Purinergic Receptor-expressing, stable replicating cell line (HEK293). Cat#: CT6190. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: QPatch™ , FLIPR®
Human TRPA1 ion channel-expressing, stable replicating cell line (CHO-K1). Cat#: CT6191. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: FLIPR®
Human TRPC6 ion channel-expressing, stable replicating cell line (HEK293). Cat#: CT6192. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: FLIPR®
Human TRPM8 ion channel-expressing, stable replicating cell line (CHO-K1). Cat#: CT6193. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: QPatch™ , FLIPR®
Human TRPV4 ion channel-expressing, stable replicating cell line (CHO-K1). Cat#: CT6194. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: FLIPR®
Human Nav1.5 sodium ion channel-expressing, stable replicating cell line (HEK293). Cat#: CT6207. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: PatchXpress®
Human TRPM2 ion channel-expressing, tetracycline-inducible, stable replicating cell line (CHO-K1). Cat#: CT6166. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: FLIPR®
Human TRPV6 ion channel-expressing, tetracycline-inducible, stable replicating cell line (HEK293). Cat#: CT6169. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: FLIPR®
hERG ion channel-expressing, division-arrested cells (CHO-K1). Cat#: CT4002. Three vials of Cryopreserved irradiated cells, 2x10E6 cells/vial (6x10E6 cells total). Platform validation: PatchXpress®
Human Nav1.7 ion channel-expressing, division-arrested cells (CHO-K1). Cat#: CT4003. Three vials of Cyropreserved irradiated cells, 2x10E6 cells/vial (6x10E6 cells total). Platform validation: PatchXpress®
Human Nav1.4 ion channel-expressing, division-arrested cells (CHO-K1). Cat#: CT4005. Three vials of Cyropreserved irradiated cells, 2x10E6 cells/vial (6x10E6 cells total). Platform validation: PatchXpress®
Human Nav1.5 ion channel-expressing, division-arrested cells (CHO-K1). Cat#: CT4007. Three vials of Cyropreserved irradiated cells, 2x10E6 cells/vial (6x10E6 cells total). Platform validation: PatchXpress®
Human Nav1.2 ion channel-expressing, division-arrested cells (CHO-K1). Cat#: CT4010. Three vials of Cyropreserved irradiated cells, 2x10E6 cells/vial (6x10E6 cells total). Platform validation: PatchXpress®
Human ASIC1a ion channel-expressing, division-arrested cells (CHO-K1). Cat#: CT4012. Three vials of Cyropreserved irradiated cells, 2x10E6 cells/vial (6x10E6 cells total). Platform validation: PatchXpress®
Human TRPM4 ion channel-expressing, division-arrested cells. (CHO). Cat#: CT4015. Cryopreserved irradiated cells, 3 vials: 2x10E6 cells/vial. Platform validation: FlexStation III
Human Kv7.4 (KCNQ4) ion channel-expressing, division-arrested cells (CHO-K1). Cat#: CT4016. Three vials of Cyropreserved irradiated cells, 2x10E6 cells/vial (6x10E6 cells total). Platform validation: PatchXpress®
